Sunday, November 8, 2026

USD/CAD Over 1% Up In The Last 21 Sessions

ViaNews Editorial Team

August 13, 2023

USD/CAD Over 1% Up In The Last 21 Sessions

(VIANEWS) - USD/CAD (USDCAD) has been up by 1.91% for the last 21 sessions. At 10:06 EST on Sunday, 13 August, USD/CAD (USDCAD) is $1.34.

USD/CAD's yearly highs and lows, it's 5.214% up from its 52-week low and 3.801% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/CAD's Forex is considered to be oversold (<=20).

Previous days news about USD/CAD (USDCAD)

  • Usd/cad price analysis: pullback towards sub-1.3400 zone appears more impulsive as US PPI looms. According to FXStreet on Friday, 11 August, "That said, USD/CAD reverses from a joint of the 200-DMA and a downward-sloping resistance line from May 31, close to 1.3450 by the press time.", "On the contrary, a daily closing beyond the 1.3450 resistance confluence could quickly propel the USD/CAD prices to the monthly high marked on Monday at around 1.3505."
  • Usd/cad remains on the defensive below mid-1.3400s, bullish potential seems intact. According to FXStreet on Friday, 11 August, "The US Dollar (USD) struggles to capitalize on the previous day's solid rebound from over a one-week low - touched in reaction to the softer US consumer inflation figures - and turns out to be a key factor acting as a headwind for the USD/CAD pair. ", "This, along with subdued Crude Oil prices and growing acceptance that the Bank of Canada (BoC) will pause its interest rate hike campaign, could undermine the commodity-linked Loonie and lend support to the USD/CAD pair. "
  • Usd/cad loses ground after hot PPI data from the US. According to FXStreet on Friday, 11 August, "At the end of the week, the USD/CAD was rejected by the 200-day Simple Moving Average(SMA) at 1.3450 and settled near 1.3430. "

More news about USD/CAD (USDCAD).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com
USD/CAD Over 1% Up In The Last 21 Sessions | Via News